Home Meetings Online CME/CE Clinical Resources EHR/EMR
Skip Navigation Links.
Activity Information

Online CME Activity

Diagnosis and Management of IBS-C for the Primary Care Provider

NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Diagnosis and Management of IBS-C for the Primary Care Provider
Release Date:
Expiration Date:
Irritable Bowel Syndrome
Primary Audience:
Primary Care
Activity Format:
1.00 AMA PRA Category 1 Credits™

CME Information

Learning Objectives:

Click here to download the IBS Patient Waiting Room Tool

Upon completion of this activity, participants should be able to:

  • Differentiate IBS-C from other common gastrointestinal motility disorders
  • Apply symptom-based criteria to the diagnosis of patients with suspected IBS-C
  • Design effective treatment strategies for patients with IBS-C
  • Educate patients regarding reasonable expectations for various IBS-C therapies
  • Summarize current data on therapies in development for the treatment of IBS-C


Written By: Lin Chang, MD, Professor of Medicine, Department of Medicine, Division of Digestive Diseases, Co-Director, Center for Neurobiology of Stress, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California

William D. Chey, MD, AGAF, FACG, FACP, Professor of Medicine, Director, GI Physiology Laboratory, Co-Director, Michigan Bowel Control Program, H. Marvin Pollard Institute Scholar, Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan

Reviewed By: Thomas Finnegan, PhD, Associate Medical Director, Curatio CME Institute

Edited By: Jonathan S. Simmons, ELS, Senior Managing Editor, Curatio CME Institute

Financial Disclosures:

Thomas Finnegan, PhD has nothing to disclose.

Jonathan S. Simmons, ELS has nothing to disclose.

Penn State faculty and staff have nothing to disclose.


Faculty Presenters

Lin Chang, MD, has disclosed the following relevant financial relationships: Consultant (investigator-initiated study): Ironwood; Consultant: Forest; Consultant/Scientific Advisory Board: Lexicon, Marathon, Prometheus, Salix, Takeda; Investigator-initiated study: Shire

William D. Chey, MD, AGAF, FACG, FACP, has disclosed the following relevant financial relationships: Consultant: Astra Zeneca, Albireo, Asubio Pharmaceuticals, Forest, Ironwood, Perrigo, Prometheus, Salix, Smartpill, Takeda; Research Project: Ironwood

Estimated Time to Complete Activity: 1 hour

Format: Internet


Statement of Need:

Irritable bowel syndrome (IBS), a chronic functional bowel disorder characterized by abdominal pain or discomfort in association with defecation or a change in bowel habit, is one of the most common problems seen by primary care providers. The overall prevalence of IBS is reported to vary between 2% and 15% in Western countries, with a predominance in female and younger patients. A chronic stable disorder, IBS is characterized by symptoms that may wax and wane for years and has been shown to impair patients’ quality of life to a similar degree as diabetes, depression, and even some domains of end-stage renal disease. Despite the prevalence and lifestyle impact, IBS is both underdiagnosed and undertreated. To address these issues, primary care providers must be aware of and able to utilize both the appropriate diagnostic criteria and treatment strategies for IBS.

Commercial Support:

Support for this activity has been provided through an educational grant from Forest Research Institute, a subsidiary of Forest Laboratories, Inc.

Education Partner:

Co-sponsored by Curatio CME Institute and Penn State College of Medicine

Accreditation and Credit Designation:

Continuing Education in the Penn State College of Medicine works to extend the academic expertise of the campus’s clinical and basic sciences. The department aims to develop and implement an integrated program of continuing professional education for health professionals on campus, in the community, throughout the Commonwealth, and at times across the nation and the world. Educational activities also provide the latest information on selected health topics to lay professionals and the general public.

Credits Type Accreditation Statement Designation Statement
1.00 AMA PRA Category 1 Credits™ Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity is co-sponsored by Curatio CME Institute, an ACCME-accredited provider. If you have any questions relating to the accreditation or your certificate for this activity, please contact Penn State at ContinuingEd@hmc.psu.edu or (717) 531-6483. Reference course #G5170-13-T Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Obtaining Credit:

Complete this online activity. Answer the questions in the attached post-activity assessment and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.